{"cdcTestId":"2013-0510","testcaseName":"# 1 at age 16 years -5 days","vaccineGroup":"MCV","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Recommended based on minimum interval from previous dose (catch-up)","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2006-10-24T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"meningococcal MCV4, unspecified formulation","cvx":"147","mvx":"","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"2","earliestDate":"2022-12-14T00:00:00","recommendedDate":"2022-12-14T00:00:00","pastDueDate":"2023-11-20T00:00:00"},"doses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"meningococcal MCV4, unspecified formulation","cvx":"147","mvx":"","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-06-01T12:22:53.433","generalDescription":"This test case describes when a first dose of a Mening vaccine is administered at 16 years - 5 days that the dose is considered to be valid.","changedInVersion":"1.0","reasonForChange":""}